Gender-independent efficacy of mesenchymal stem cell therapy in sex hormone-deficient bone loss via immunosuppression and resident stem cell recovery |
Sui, Bing-Dong
(State Key Laboratory of Military Stomatology, Center for Tissue Engineering, Fourth Military Medical University)
Chen, Ji (State Key Laboratory of Military Stomatology, Center for Tissue Engineering, Fourth Military Medical University) Zhang, Xin-Yi (State Key Laboratory of Military Stomatology, Center for Tissue Engineering, Fourth Military Medical University) He, Tao (State Key Laboratory of Military Stomatology, Center for Tissue Engineering, Fourth Military Medical University) Zhao, Pan (State Key Laboratory of Military Stomatology, Center for Tissue Engineering, Fourth Military Medical University) Zheng, Chen-Xi (State Key Laboratory of Military Stomatology, Center for Tissue Engineering, Fourth Military Medical University) Li, Meng (State Key Laboratory of Military Stomatology, Center for Tissue Engineering, Fourth Military Medical University) Hu, Cheng-Hu (State Key Laboratory of Military Stomatology, Center for Tissue Engineering, Fourth Military Medical University) Jin, Yan (State Key Laboratory of Military Stomatology, Center for Tissue Engineering, Fourth Military Medical University) |
1 | Jackson, J. A. & Kleerekoper, M. Osteoporosis in men: diagnosis, pathophysiology, and prevention. Medicine 69, 137-152 (1990). DOI |
2 | Moverare-Skrtic, S. et al. Osteoblast-derived WNT16 represses osteoclastogenesis and prevents cortical bone fragility fractures. Nat. Med. 20, 1279-1288 (2014). DOI |
3 | Hannan, M. T., Felson, D. T. & Anderson, J. J. Bone mineral density in elderly men and women: results from the Framingham osteoporosis study. J. Bone Miner. Res. 7, 547-553 (1992). |
4 | Pacifici, R. Estrogen, cytokines, and pathogenesis of postmenopausal osteoporosis. J. Bone Miner. Res. 11, 1043-1051 (1996). |
5 | Sui BD, et al. Stem cell-based bone regeneration in diseased microenvironments: Challenges and solutions. Biomaterials 2017; e-pub ahead of print 30 October 2017. https://doi.org/10.1016/j.biomaterials.2017.10.046. DOI |
6 | Sui, B. D., Hu, C. H., Zheng, C. X. & Jin, Y. Microenvironmental Views on Mesenchymal Stem Cell Differentiation in Aging. J. Dent. Res. 95, 1333-1340 (2016). DOI |
7 | Liu, Y., Wu, J., Zhu, Y. & Han, J. Therapeutic application of mesenchymal stem cells in bone and joint diseases. Clin. Exp. Med. 14, 13-24 (2014). DOI |
8 | Shi, Y. et al. Mesenchymal stem cells: a new strategy for immunosuppression and tissue repair. Cell Res. 20, 510-518 (2010). DOI |
9 | Sui, B. D. et al. Recipient Glycemic Micro-environments Govern Therapeutic Effects of Mesenchymal Stem Cell Infusion on Osteopenia. Theranostics 7, 1225-1244 (2017). DOI |
10 | Liu, Y. et al. Transplantation of SHED prevents bone loss in the early phase of ovariectomy-induced osteoporosis. J. Dent. Res. 93, 1124-1132 (2014). DOI |
11 | Cho, S. W. et al. Transplantation of mesenchymal stem cells overexpressing RANK-Fc or CXCR4 prevents bone loss in ovariectomized mice. Mol. Ther. 17, 1979-1987 (2009). DOI |
12 | Cenci, S. et al. Estrogen deficiency induces bone loss by enhancing T-cell production of TNF-alpha. J. Clin. Invest. 106, 1229-1237 (2000). DOI |
13 | Yuan, X. et al. Psoralen and isopsoralen Ameliorate sex hormone deficiencyinduced osteoporosis in female and male mice. Biomed. Res. Int. 2016, 6869452 (2016). |
14 | Fujita, T. et al. Breadth of the mandibular condyle affected by disturbances of the sex hormones in ovariectomized and orchiectomized mice. Clin. Orthod. Res. 4, 172-176 (2001). DOI |
15 | Cenci, S. et al. Estrogen deficiency induces bone loss by increasing T cell proliferation and lifespan through IFN-gamma-induced class II transactivator. Proc. Natl Acad. Sci. USA 100, 10405-10410 (2003). DOI |
16 | Wang, L. et al. IFN-gamma and TNF-alpha synergistically induce mesenchymal stem cell impairment and tumorigenesis via NFkappaB signaling. Stem Cells 31, 1383-1395 (2013). DOI |
17 | Cawthon, P. M. Gender differences in osteoporosis and fractures. Clin. Orthop. Relat. Res. 469, 1900-1905 (2011). DOI |
18 | Rupich, R. C., Specker, B. L., Lieuw-A-Fa, M. & Ho, M. Gender and race differences in bone mass during infancy. Calcif. Tissue Int. 58, 395-397 (1996). DOI |
19 | Gilsanz, V. et al. Gender differences in vertebral body sizes in children and adolescents. Radiology 190, 673-677 (1994). DOI |
20 | Aaron, J. E., Makins, N. B. & Sagreiya, K. The microanatomy of trabecular bone loss in normal aging men and women. Clin. Orthop. Relat. Res. 215, 260-271 (1987). |
21 | Sui, B. et al. Allogeneic mesenchymal stem cell therapy promotes osteoblastogenesis and prevents glucocorticoid-induced osteoporosis. Stem Cells Transl. Med. 5, 1238-1246 (2016). DOI |
22 | Lee, K. et al. Systemic transplantation of human adipose-derived stem cells stimulates bone repair by promoting osteoblast and osteoclast function. J. Cell. Mol. Med. 15, 2082-2094 (2011). DOI |
23 | An, J. H. et al. Transplantation of human umbilical cord blood-derived mesenchymal stem cells or their conditioned medium prevents bone loss in ovariectomized nude mice. Tissue Eng. Part. A. 19, 685-696 (2013). DOI |
24 | Nielson, C. M., Klein, R. F. & Orwoll, E. S. Sex and the single nucleotide polymorphism: exploring the genetic causes of skeletal sex differences. J. Bone Miner. Res. 27, 2047-2050 (2012). DOI |
25 | Lien, C. Y., Chih-Yuan, Ho. K., Lee,O. K., Blunn,G. W. & Su, Y. Restoration of bone mass and strength in glucocorticoid-treated mice by systemic transplantation of CXCR4 and cbfa-1 co-expressing mesenchymal stem cells. J. Bone Miner. Res. 24, 837-848 (2009). DOI |
26 | Ma, L. et al. Transplantation of mesenchymal stem cells ameliorates secondary osteoporosis through interleukin-17-impaired functions of recipient bone marrow mesenchymal stem cells in MRL/lpr mice. Stem Cell Res. Ther. 6, 104 (2015). DOI |
27 | Akiyama, K. et al. Mesenchymal-stem-cell-induced immunoregulation involves FAS-ligand-/FAS-mediated T cell apoptosis. Cell. Stem Cell 10, 544-555 (2012). DOI |
28 | Khosla, S., Oursler, M. J. & Monroe, D. G. Estrogen and the skeleton. Trends Endocrinol. Metab. 23, 576-581 (2012). DOI |
29 | Most, W., van der Wee-Pals, L., Ederveen, A., Papapoulos, S. & Lowik, C. Ovariectomy and orchidectomy induce a transient increase in the osteoclastogenic potential of bone marrow cells in the mouse. Bone 20, 27-30 (1997). DOI |
30 | Turner, R. T., Wakley, G. K. & Hannon, K. S. Differential effects of androgens on cortical bone histomorphometry in gonadectomized male and female rats. J. Orthop. Res. 8, 612-617 (1990). DOI |
31 | Novack, D. V. Estrogen and bone: osteoclasts take center stage. Cell. Metab. 6, 254-256 (2007). DOI |
32 | Weitzmann, M. N. & Pacifici, R. Estrogen deficiency and bone loss: an inflammatory tale. J. Clin. Invest. 116, 1186-1194 (2006). DOI |
33 | Clowes, J. A., Riggs, B. L. & Khosla, S. The role of the immune system in the pathophysiology of osteoporosis. Immunol. Rev. 208, 207-227 (2005). DOI |
34 | Pfeilschifter, J., Koditz, R., Pfohl, M. & Schatz, H. Changes in proinflammatory cytokine activity after menopause. Endocr. Rev. 23, 90-119 (2002). DOI |
35 | Finkelstein, J. S. et al. Osteoporosis in men with idiopathic hypogonadotropic hypogonadism. Ann. Intern Med 106, 354-361 (1987). DOI |
36 | Yang, N. et al. Tumor necrosis factor alpha suppresses the mesenchymal stem cell osteogenesis promoter miR-21 in estrogen deficiency-induced osteoporosis. J. Bone Miner. Res. 28, 559-573 (2013). DOI |
37 | Liao, L. et al. TNF-alpha Inhibits FoxO1 by Upregulating miR-705 to Aggravate Oxidative Damage in Bone Marrow-Derived Mesenchymal Stem Cells during Osteoporosis. Stem Cells 34, 1054-1067 (2016). DOI |
38 | Seeman, E. During aging, men lose less bone than women because they gain more periosteal bone, not because they resorb less endosteal bone. Calcif. Tissue Int. 69, 205-208 (2001). DOI |
39 | Vandenput, L. & Ohlsson, C. Estrogens as regulators of bone health in men. Nat. Rev. Endocrinol. 5, 437-443 (2009). DOI |
40 | Francis, R. M. Androgen replacement in aging men. Calcif. Tissue Int. 69, 235-238 (2001). DOI |
41 | Sui, B., Hu, C. & Jin, Y. Mitochondrial metabolic failure in telomere attritionprovoked aging of bone marrow mesenchymal stem cells. Biogerontology 17, 267-279 (2016). DOI |
42 | Sui, B. et al. Mesenchymal progenitors in osteopenias of diverse pathologies: differential characteristics in the common shift from osteoblastogenesis to adipogenesis. Sci. Rep. 6, 30186 (2016). DOI |
43 | Shao, B. et al. Estrogen preserves Fas ligand levels by inhibiting microRNA-181a in bone marrow-derived mesenchymal stem cells to maintain bone remodeling balance. FASEB J. 29, 3935-3944 (2015). DOI |
44 | Zheng, C., Sui, B., Hu, C. & Jin, Y. Vitamin C promotes in vitro proliferation of bone marrow mesenchymal stem cells derived from aging mice. Nan. Fang. Yi. Ke. Da. Xue. Xue. Bao. 35, 1689-1693 (2015). |
45 | Bouxsein, M. L. et al. Guidelines for assessment of bone microstructure in rodents using micro-computed tomography. J. Bone Miner. Res. 25, 1468-1486 (2010). DOI |
46 | Stepan, J. J., Lachman, M., Zverina, J., Pacovsky, V. & Baylink, D. J. Castrated men exhibit bone loss: effect of calcitonin treatment on biochemical indices of bone remodeling. J. Clin. Endocrinol. Metab. 69, 523-527 (1989). DOI |
47 | Alibhai, S. M., Gogov, S. & Allibhai, Z. Long-term side effects of androgen deprivation therapy in men with non-metastatic prostate cancer: a systematic literature review. Crit. Rev. Oncol. Hematol. 60, 201-215 (2006). DOI |
48 | Baillie, S. P., Davison, C. E., Johnson, F. J. & Francis, R. M. Pathogenesis of vertebral crush fractures in men. Age Ageing 21, 139-141 (1992). DOI |
49 | Chen, N. et al. microRNA-21 Contributes to Orthodontic Tooth Movement. J. Dent. Res. 95, 1425-1433 (2016). DOI |
50 | Hu, C. H. et al. miR-21 deficiency inhibits osteoclast function and prevents bone loss in mice. Sci. Rep. 7, 43191 (2017). DOI |
51 | Dempster, D. W. et al. Standardized nomenclature, symbols, and units for bone histomorphometry: a 2012 update of the report of the ASBMR Histomorphometry Nomenclature Committee. J. Bone Miner. Res. 28, 2-17 (2013). DOI |
52 | Zhao, P. et al. Anti-aging pharmacology in cutaneous wound healing: effects of metformin, resveratrol, and rapamycin by local application. Aging Cell 16, 1083-1093 (2017). DOI |
53 | Liao, L. et al. Redundant miR-3077-5p and miR-705 mediate the shift of mesenchymal stem cell lineage commitment to adipocyte in osteoporosis bone marrow. Cell Death Dis. 4, e600 (2013). DOI |
54 | Liu, S. et al. MSC Transplantation Improves Osteopenia via Epigenetic Regulation of Notch Signaling in Lupus. Cell. Metab. 22, 606-618 (2015). DOI |
55 | Gunness, M. & Orwoll, E. Early induction of alterations in cancellous and cortical bone histology after orchiectomy in mature rats. J. Bone Miner. Res. 10, 1735-1744 (1995). |
56 | Zhang, X. S. et al. Local ex vivo gene therapy with bone marrow stromal cells expressing human BMP4 promotes endosteal bone formation in mice. J. Gene Med. 6, 4-15 (2004). DOI |
57 | Mirsaidi, A. et al. Therapeutic potential of adipose-derived stromal cells in agerelated osteoporosis. Biomaterials 35, 7326-7335 (2014). DOI |
58 | Chen, C. et al. Mesenchymal stem cell transplantation in tight-skin mice identifies miR-151-5p as a therapeutic target for systemic sclerosis. Cell Res. 27, 559-577 (2017). DOI |
59 | Tan, R. et al. GAPDH is critical for superior efficacy of female bone marrowderived mesenchymal stem cells on pulmonary hypertension. Cardiovasc. Res. 100, 19-27 (2013). DOI |
60 | Sammour, I. et al. The Effect of Gender on Mesenchymal Stem Cell (MSC) Efficacy in Neonatal Hyperoxia-Induced Lung Injury. PLoS ONE 11, e0164269 (2016). DOI |